Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Zug, Switzerland
SEC filing record 1 source field available
Fiscal year end
31 December
MoonLake Immunotherapeutics has filed 316 SEC EDGAR filings since 28 Aug 2020

SEC filing history

Showing 101-125 of 316 matching filings.

Per page
25
Current page
5
4

OWNERSHIP DOCUMENT

Filing date
10 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
10 Jun 2024
Reporting date
10 Jun 2024
Next action
Verify source filing
4

4 filing

Filing date
07 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
06 Jun 2024
Reporting date
05 Jun 2024
Next action
Verify source filing
UPLOAD File 001-39630

UPLOAD filing

Filing date
13 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 001-39630

UPLOAD filing

Filing date
29 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-39630

ARS

Filing date
24 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39630

DEFA14A

Filing date
24 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39630

DEF 14A

Filing date
24 Apr 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
11 Mar 2024
Reporting date
10 Mar 2024
Next action
Verify source filing
SC 13D/A File 005-91803

AMENDMENT NO. 2 TO SCHEDULE 13D

Filing date
05 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39630

CURRENT REPORT

Filing date
26 Feb 2024
Reporting date
26 Feb 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .